Copy Link Print Information

Atibuclimab

(Synonyms: IC14)
2 Cited Publications
Revisión del cliente

Based on 2 publication(s) in Google Scholar

Atibuclimab (IC14), is a chimeric monoclonal antibody directed against CD14 and is composed of murine variable and human IgG4 Fc regions. Atibuclimab attenuates Lipopolysaccharides (HY-D1056) (LPS)-induced symptoms and strongly inhibits LPS-induced proinflammatory cytokine release, while only delaying the release of the anti-inflammatory cytokines soluble TNF receptor type I and IL-1 receptor antagonist. Atibuclimab can be used for the research of amyotrophic lateral sclerosis, sepsis, community-acquired pneumonia, or acute lung injury.

Para uso exclusivo en investigación. No vendemos a pacientes.

  • Pureza: ≥99.0%
  • No. CAS: 2417175-94-9
  • Peso molecular:145.5 kDa
  • Almacenamiento:

    Please store the product under the recommended conditions in the Certificate of Analysis.

  • Experimental Validation Results for Atibuclimab
  • Experimental Validation Results for Atibuclimab
  • Experimental Validation Results for Atibuclimab
  • Atibuclimab Chemical Structure
    Atibuclimab Chemical Structure
No. CAS: 2417175-94-9
Tamaño
Precio
Stock
Cantidad
Amount: USD 0.00
Please select quantity
or
or

* Seleccione Cantidad antes de agregar artículos.

To place orders, for customer services and technical support, please contact: MedChemExpress USA

Tel: 609-228-6898 E-mail: [email protected] [email protected]

Data Download
Atibuclimab Product Recommendations:

To place orders, for customer services and technical support, please contact:

609-228-6898
[email protected] [email protected]
Encuentre su distribuidor local Your local distributor: Hycultec GmbHHycultec
  • Actividad biológica
  • Chemical Information
  • Pureza y Documentación
  • Referencias
  • Help & FAQs
You May Still Need
Top Publications Citing

Use of MCE Products

Publications Citing Use of MedChemExpress (MCE) Atibuclimab

More

Ver todos los productos específicos de isoformas Toll-like Receptor (TLR)

More
Keywords
MOQ
Minimum order quantity
100 mg

Obtener un presupuesto En stock

Other size
Obtener un presupuesto
Please select quantity
Amount: USD 0.00
Sign in to MedChemExpress Inicie sesiòn
Registrar
Sign in to MedChemExpress
Registrar una cuenta nueva

At least 6 characters

Personalize your experience, you are currently not signed in. For a better experience, please create an online profile, you can:

Obtain points redemption prizes
Check out faster
Add multiple shipping locations
View orders
Assay Types
  • 1/16

    Human IgG4 kappa

  • 1/16

    Immobilized CD14 Protein, Human (HEK293, His, HY-P7786) can bind Atibuclimab. The EC50 for this effect is 22.13 ng/mL.

  • 1/16

    Flow Cytometry analysis of Raji cells labelling CD14 (red) with Atibuclimab (anti-CD14) (HY-P99008). Cells were stained with the primary antibody at 1/200 dilution for an hour at 4℃. Goat Anti-Human IgG H&L (AF488) (HY-P83776) was used as the secondary antibody at 1/1,000 dilution for 30 minutes at 4℃. Human IgG4 kappa (HY-P99003, blue) was used as the isotype control, cells without incubation with primary antibody were used as the unlabeled control (black).

  • Atibuclimab Chemical Structure
    1/16
  • Atibuclimab
  • Immobilized CD14 Protein, Human (HEK293, His, HY-P7786) can bind Atibuclimab. The EC50 for this effect is 22.13 ng/mL.
  • Flow Cytometry analysis of Raji cells labelling CD14 (red) with Atibuclimab (anti-CD14) (HY-P99008). Cells were stained with the primary antibody at 1/200 dilution for an hour at 4℃. Goat Anti-Human IgG H&L (AF488) (HY-P83776) was used as the secondary antibody at 1/1,000 dilution for 30 minutes at 4℃. Human IgG4 kappa (HY-P99003, blue) was used as the isotype control, cells without incubation with primary antibody were used as the unlabeled control (black).